Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Dividends

Explore dividend yields, payout ratios, and historical trends to maximize your investment strategies.

Last Close
May 28 04:00PM ET
Dollar change
Percentage change
IndexRUT P/E29.79 EPS (ttm)1.43 Insider Own78.48% Shs Outstand37.58M Perf Week0.64%
Market Cap1.60B Forward P/E- EPS next Y- Insider Trans0.00% Shs Float8.09M Perf Month0.68%
Income53.87M PEG- EPS next Q- Inst Own12.77% Short Float0.91% Perf Quarter1.33%
Sales629.18M P/S2.55 EPS this Y- Inst Trans0.49% Short Ratio2.34 Perf Half Y16.86%
Book/sh47.34 P/B0.90 EPS next Y- ROA2.51% Short Interest0.07M Perf Year47.36%
Cash/sh23.40 P/C1.82 EPS next 5Y-12.95% ROE3.06% 52W Range28.10 - 45.76 Perf YTD2.18%
Dividend Est.- P/FCF20.15 EPS past 5Y-27.64% ROI3.03% 52W High-6.71% Beta0.56
Dividend TTM- Quick Ratio3.04 Sales past 5Y-0.89% Gross Margin52.11% 52W Low51.92% ATR (14)0.23
Dividend Ex-DateDec 10, 2018 Current Ratio3.61 EPS Y/Y TTM111.70% Oper. Margin3.42% RSI (14)60.58 Volatility0.42% 0.54%
Employees1554 Debt/Eq0.00 Sales Y/Y TTM9.81% Profit Margin8.56% Recom3.00 Target Price43.00
Option/ShortYes / Yes LT Debt/Eq0.00 EPS Q/Q118.16% Payout0.00% Rel Volume1.46 Prev Close42.69
Sales Surprise5.69% EPS Surprise29.03% Sales Q/Q12.52% EarningsMay 20 AMC Avg Volume31.44K Price42.69
SMA200.60% SMA500.96% SMA2007.32% Trades Volume54,908 Change0.00%
Date Action Analyst Rating Change Price Target Change
Jan-18-24Downgrade H.C. Wainwright Buy → Neutral $43
Jul-27-20Reiterated H.C. Wainwright Buy $96 → $82
Feb-04-20Reiterated H.C. Wainwright Buy $110 → $94
Nov-05-19Reiterated H.C. Wainwright Buy $105 → $110
Mar-12-18Initiated H.C. Wainwright Buy $124
May-23-17Downgrade Credit Suisse Outperform → Neutral
May-23-24 08:10AM
May-20-24 09:53PM
09:00AM Loading…
May-15-24 09:00AM
May-08-24 09:07AM
Apr-15-24 08:00AM
Mar-07-24 12:00AM
Mar-06-24 12:30PM
Jan-30-24 01:41PM
Jan-29-24 11:01PM
Jan-25-24 05:13PM
05:06PM Loading…
Jan-23-24 02:45PM
Jan-20-24 11:29AM
Jan-19-24 04:15PM
Jan-18-24 01:52PM
Jan-17-24 04:30PM
Oct-26-23 05:12PM
Oct-19-23 04:30PM
Jul-27-23 05:32AM
Jul-26-23 08:36PM
Jul-19-23 04:00PM
09:00AM Loading…
Jun-30-23 09:00AM
May-30-23 12:25PM
May-23-23 07:28PM
May-18-23 04:46PM
Apr-17-23 01:35PM
Jan-27-23 06:01AM
Jan-24-23 05:43PM
Jan-19-23 05:02PM
Oct-27-22 07:55PM
Oct-24-22 12:37PM
Oct-12-22 10:58AM
Aug-11-22 06:17PM
Jul-27-22 07:05PM
Jul-26-22 04:10PM
Jul-06-22 06:10AM
May-26-22 07:00PM
May-23-22 05:35PM
May-20-22 07:00PM
May-17-22 08:15AM
May-16-22 09:05AM
May-13-22 09:55AM
May-12-22 08:15AM
May-05-22 10:29AM
May-04-22 08:45AM
Feb-28-22 06:19PM
Feb-22-22 09:23AM
Jan-27-22 07:15PM
Jan-25-22 08:11AM
Jan-20-22 08:45PM
Jan-19-22 03:01PM
Jan-05-22 07:48AM
Dec-01-21 05:05PM
Nov-15-21 12:15PM
Oct-28-21 06:45PM
Oct-27-21 11:18AM
Oct-21-21 01:01PM
Oct-20-21 03:03PM
Jul-29-21 07:44AM
Jul-27-21 08:45PM
Jul-20-21 09:05PM
Jul-19-21 06:49AM
Jul-14-21 05:54PM
Jun-18-21 10:00AM
May-19-21 05:30PM
May-12-21 05:58PM
Mar-09-21 05:37AM
Jan-27-21 05:46PM
Jan-20-21 08:28PM
Dec-12-20 07:48PM
Oct-29-20 06:00AM
Oct-28-20 06:45PM
Oct-21-20 06:44PM
Sep-28-20 01:01PM
Sep-10-20 03:19PM
Jul-29-20 06:55PM
Jul-23-20 04:32PM
Jul-22-20 02:37PM
Jun-25-20 06:45PM
Jun-19-20 09:30AM
May-29-20 05:41PM
Taro Pharmaceutical Industries Ltd. engages in the development, manufacturing and marketing of prescribed and over-the-counter pharmaceutical products in the U.S., Canada and Israel. Its products include semi-solids formulations, such as creams and ointments and other dosage forms such as liquids, capsules and tablets, in the dermatological and topical, cardiovascular, neuropsychiatric and anti-inflammatory therapeutic categories. The company was founded in 1950 and is headquartered in Haifa Bay, Israel.